Galectin Therapeutics Inc. · NASDAQ:GALT
Galectin Therapeutics Inc. shareholders
As of Sep 30, 2026, 102 institutions reported holding Galectin Therapeutics Inc., 15.9% of its shares. Largest: BlackRock, Vanguard and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Galectin Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 3.38M | 3.3% | +390K | Nov 13, 2026 |
| Vanguard | 2.78M | 2.8% | −103K | Nov 13, 2026 |
| Geode Capital | 1.25M | 1.2% | −61,835 | Nov 6, 2026 |
| Osaic Holdings, Inc. | 1.21M | 1.2% | +6,451 | Nov 12, 2026 |
| State Street | 801K | 0.79% | +233K | Nov 12, 2026 |
| Wealthspire Advisors, LLC | 722K | 0.72% | no change | Nov 13, 2026 |
| Corient Private Wealth LP | 542K | 0.54% | new | Nov 16, 2026 |
| Marshall Wace, LLP | 467K | 0.46% | −364K | Nov 13, 2026 |
| Commonwealth Equity Services, LLC | 460K | 0.46% | +53,183 | Nov 2, 2026 |
| Northern Trust | 376K | 0.37% | −10,589 | Nov 16, 2026 |